New Alzheimer Drugs on the Horizon!
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F<br />
I<br />
N<br />
DI N G S<br />
The outcome at <strong>on</strong>e year was m<strong>on</strong>umental! The higher <strong>the</strong> drug dose, <strong>the</strong><br />
fewer patients erred <strong>on</strong> clinical tests of memory and thinking. Aducanumab<br />
subjects dem<strong>on</strong>strated 70 percent less mental decline than placebo patients!<br />
Study participants also underwent brain imaging, with radioactive tracers<br />
used to identify brain plaques. Aducanumab reduced plaque depositi<strong>on</strong> in six<br />
brain regi<strong>on</strong>s. In placebo subjects, protein clumps remained unchanged.<br />
Low doses of <strong>the</strong> drug didn’t impact brain plaque. However, both medium and<br />
high doses noticeably lowered plaque levels.
![Projected Senior Populations in the State of Ohio [Infographic]](https://img.yumpu.com/54840652/1/190x107/projected-senior-populations-in-the-state-of-ohio-infographic.jpg?quality=85)
Change language